DNA-testing company 23andMe and its co-founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at factors that knocked the company’s valuation down to nearly $0. Photo: Peter DaSilva/Reuters Photo: Peter DaSilva/Reuters